At-home fingerprick test could replace clinic visits for diabetes screening

NCT ID NCT07155252

Recruiting now Diagnosis Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a self-administered fingerstick glucose tolerance test done at home can accurately measure blood sugar levels compared to the standard clinic-based test. Researchers will enroll 60 people at risk for or recently diagnosed with type 1 diabetes. If accurate, this approach could make screening more convenient and accessible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: self-administered fingerstick glucose tolerance test
What this could lead to: If accurate, this could allow people at risk for type 1 diabetes to be screened at home instead of going to a clinic.
What could go wrong: This is a small early study with only 60 participants, so results may not apply to everyone. The home test may be less accurate than the clinic version.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Yale University Pediatric and Adult Diabetes Clinic
RECRUITING

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.